Yipin Pharmaceutical

Based in China, Yipin Pharmaceutical, operates as a pharmaceutical manufacturer, focusing on general anesthetics and their raw materials. Based in Shijiazhuang, China and founded in 2013, Yipin Pharmaceutical operates as a pharmaceutical manufacturer. The company specializes in the production of general anesthetics and their raw materials. The funding will primarily be used for product development and capacity expansion.

Hebei Yipin Pharmaceutical Co. , Ltd. specializes in the production, research and development, and sales of a diverse range of pharmaceutical products aimed at addressing various health needs. The company adheres to national drug production quality management standards (GMP), ensuring the delivery of safe and effective medications.

Their product line spans multiple therapeutic areas, targeting different patient populations, and reflects their commitment to improving healthcare outcomes. The company serves medical institutions, healthcare providers, and patients across several geographical markets, focusing on expanding their reach to international markets and collaborating with global pharmaceutical enterprises. Hebei Yipin Pharmaceutical Co. , Ltd.

generates revenue through direct sales of its pharmaceutical products to healthcare facilities, pharmaceutical retailers, and potentially through other distribution partnerships. The company employs a B2B transaction model, ensuring that its products reach the intended end-users effectively. Sales transactions typically involve the purchase of bulk pharmaceuticals, with established agreements for pricing and delivery terms that align with industry standards. By expanding its sales network and enhancing brand recognition in the market, the company aims to solidify its revenue streams, driven by the demand for its high-quality and innovative pharmaceutical solutions.

The company plans to utilize the recent funding for product development and capacity expansion.